The relevance of mouse models for investigating age-related bone loss in humans

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 68, Issue 10, 2013, Pages 1209-1217

  Jilka, Robert L ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Aging; Bones; Osteoporosis

Indexed keywords

ANIMAL; ATHEROSCLEROSIS; BONE DENSITY; DISEASE MODEL; HUMAN; MOUSE; OSTEOPOROSIS; PATHOLOGY; PATHOPHYSIOLOGY; PREMATURE AGING; SPECIES DIFFERENCE; AGING; BONES; REVIEW;

AGING, PREMATURE; ANIMALS; ATHEROSCLEROSIS; BONE DENSITY; DISEASE MODELS, ANIMAL; HUMANS; MICE; OSTEOPOROSIS; SPECIES SPECIFICITY;

AGING; BONES; OSTEOPOROSIS;

EID: 84885002960     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glt046     Document Type: Article

References (97)

1. Kalu DN. The ovariectomized rat model of postmenopausal bone loss. Bone Miner. 1991;15:175-191.
2. Jerome CP. Primate models of osteoporosis. Lab Anim Sci. 1998;48:618-622. (Pubitemid 29075066)
3. Manolagas SC. From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis. Endocr Rev. 2010;31:266-300.
4. Khosla S. Pathogenesis of Age-Related Bone Loss in Humans. J Gerontol A Biol Sci Med Sci. 2012. doi: 10.1093/gerona/gls163.
5. Zebaze RM, Ghasem-Zadeh A, Bohte A, et al. Intracortical remodelling and porosity in the distal radius and post-mortem femurs of women: a cross-sectional study. Lancet. 2010;375:1729-1736.
6. Nicks KM, Amin S, Atkinson EJ, Riggs BL, Melton LJ 3rd, Khosla S. Relationship of age to bone microstructure independent of areal bone mineral density. J Bone Miner Res. 2012;27:637-644.
7. Colman RJ, Lane MA, Binkley N, Wegner FH, Kemnitz JW. Skeletal effects of aging in male rhesus monkeys. Bone. 1999;24:17-23. (Pubitemid 28546701)
8. Duque G, Rivas D, Li W, et al. Age-related bone loss in the LOU/c rat model of healthy ageing. Exp Gerontol. 2009;44:183-189.
9. Halloran BP, Ferguson VL, Simske SJ, Burghardt A, Venton LL, Majumdar S. Changes in bone structure and mass with advancing age in the male C57BL/6J mouse. J Bone Miner Res. 2002;17:1044-1050. (Pubitemid 34535142)
10. Ferguson VL, Ayers RA, Bateman TA, Simske SJ. Bone development and age-related bone loss in male C57BL/6J mice. Bone. 2003;33:387-398. (Pubitemid 37107464)
11. Glatt V, Canalis E, Stadmeyer L, Bouxsein ML. Age-related changes in trabecular architecture differ in female and male C57BL/6J mice. J Bone Miner Res. 2007;22:1197-1207. (Pubitemid 351339702)
12. Almeida M, Han L, Martin-Millan M, et al. Skeletal involution by age-associated oxidative stress and its acceleration by loss of sex steroids. J Biol Chem. 2007;282:27285-27297. (Pubitemid 47501960)
13. Green DR, Galluzzi L, Kroemer G. Mitochondria and the autophagyinflammation- cell death axis in organismal aging. Science. 2011;333:1109-1112.
14. Rodier F, Campisi J. Four faces of cellular senescence. J Cell Biol. 2011;192:547-556.
15. Lee HY, Choi CS, Birkenfeld AL, et al. Targeted expression of catalase to mitochondria prevents age-associated reductions in mitochondrial function and insulin resistance. Cell Metab. 2010;12:668-674.
16. Storz P. Forkhead homeobox type O transcription factors in the responses to oxidative stress. Antioxid Redox Signal. 2011;14:593-605.
17. Pérez VI, Bokov A, Van Remmen H, et al. Is the oxidative stress theory of aging dead? Biochim Biophys Acta. 2009;1790:1005-1014.
18. Manolagas SC. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev. 2000;21:115-137. (Pubitemid 32275592)
19. Seeman E, Delmas PD. Bone quality-the material and structural basis of bone strength and fragility. N Engl J Med. 2006;354:2250-2261.
20. Tang Y, Wu X, Lei W, et al. TGF-beta1-induced migration of bone mesenchymal stem cells couples bone resorption with formation. Nat Med. 2009;15:757-765.
21. Jilka RL, Weinstein RS, Parfitt AM, Manolagas SC. Quantifying osteoblast and osteocyte apoptosis: challenges and rewards. J Bone Miner Res. 2007;22:1492-1501. (Pubitemid 351229319)
22. Bonewald LF. The amazing osteocyte. J Bone Miner Res. 2011;26:229-238.
23. Nakashima T, Hayashi M, Fukunaga T, et al. Evidence for osteocyte regulation of bone homeostasis through RANKL expression. Nat Med. 2011;17:1231-1234.
24. Xiong J, Onal M, Jilka RL, Weinstein RS, Manolagas SC, O'Brien CA. Matrix-embedded cells control osteoclast formation. Nat Med. 2011;17:1235-1241.
25. Kennedy OD, Herman BC, Laudier DM, Majeska RJ, Sun HB, Schaffler MB. Activation of resorption in fatigue-loaded bone involves both apoptosis and active pro-osteoclastogenic signaling by distinct osteocyte populations. Bone. 2012;50:1115-1122.
26. Almeida M, O'Brien CA. Basic biology of skeletal aging. J Gerontol A Biol Sci Med Sci. In press.
27. Chia R, Achilli F, Festing MF, Fisher EM. The origins and uses of mouse outbred stocks. Nat Genet. 2005;37:1181-1186. (Pubitemid 41568697)
28. Beck JA, Lloyd S, Hafezparast M, et al. Genealogies of mouse inbred strains. Nat Genet. 2000;24:23-25. (Pubitemid 30041415)
29. Maddatu TP, Grubb SC, Bult CJ, Bogue MA. Mouse Phenome Database (MPD). Nucleic Acids Res. 2012;40(Database issue):D887-D894.
30. Miller RA, Austad S, Burke D, et al. Exotic mice as models for aging research: polemic and prospectus. Neurobiol Aging. 1999;20:217-231. (Pubitemid 29488732)
31. Festing MF. Warning: the use of heterogeneous mice may seriously damage your research. Neurobiol Aging. 1999;20:237-44; discussion 245. (Pubitemid 29488734)
32. Miller RA, Harper JM, Galecki A, Burke DT. Big mice die young: early life body weight predicts longevity in genetically heterogeneous mice. Aging Cell. 2002;1:22-29.
33. Yuan R, Tsaih SW, Petkova SB, et al. Aging in inbred strains of mice: study design and interim report on median lifespans and circulating IGF1 levels. Aging Cell. 2009;8:277-287.
34. Seok J, Warren HS, Cuenca AG, et al. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci USA. 2013;110:3507-3512.
35. Ferron M, Wei J, Yoshizawa T, et al. Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism. Cell. 2010;142:296-308.
36. Schwartz AV, Schafer AL, Grey A, et al. Effects of antiresorptive therapies on glucose metabolism: results from the FIT, HORIZON-PFT and FREEDOM trials. J Bone Miner Res. 2013. doi:10.1002/jbmr.1865.
37. Ackert-Bicknell C, Beamer WG, Rosen CJ, Sundberg JP. Aging Study: Bone Mineral Density and Body Composition of 32 Inbred Strains of Mice. MPD;Ackert1. Mouse Phenome Database Web Site. Bar Harbor, ME: The Jackson Laboratory. http://phenome.jax.org
38. Parfitt AM. Misconceptions (1): epiphyseal fusion causes cessation of growth. Bone. 2002;30:337-339. (Pubitemid 34150155)
39. Bonkowski MS, Pamenter RW, Rocha JS, Masternak MM, Panici JA, Bartke A. Long-lived growth hormone receptor knockout mice show a delay in age-related changes of body composition and bone characteristics. J Gerontol A Biol Sci Med Sci. 2006;61:562-567.
40. Miller RA, Kreider J, Galecki A, Goldstein SA. Preservation of femoral bone thickness in middle age predicts survival in genetically heterogeneous mice. Aging Cell. 2011;10:383-391.
41. He J, Rosen CJ, Adams DJ, Kream BE. Postnatal growth and bone mass in mice with IGF-I haploinsufficiency. Bone. 2006;38:826-835. (Pubitemid 44498595)
42. Courtland HW, Kennedy OD, Wu Y, et al. Low levels of plasma IGF-1 inhibit intracortical bone remodeling during aging. Age (Dordr). 2012. doi:10.1007/s11357-012-9469-8.
43. Jilka RL, O'Brien CA, Bartell SM, Weinstein RS, Manolagas SC. Continuous elevation of PTH increases the number of osteoblasts via both osteoclast-dependent and -independent mechanisms. J Bone Miner Res. 2010;25:2427-2437.
44. Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J Clin Invest. 1998;102:274-282. (Pubitemid 28335186)
45. Jilka RL, O'Brien CA, Ali AA, Roberson PK, Weinstein RS, Manolagas SC. Intermittent PTH stimulates periosteal bone formation by actions on post-mitotic preosteoblasts. Bone. 2009;44:275-286.
46. Parfitt AM. Misconceptions (2): turnover is always higher in cancellous than in cortical bone. Bone. 2002;30:807-809. (Pubitemid 34616005)
47. Parfitt AM, Han ZH, Palnitkar S, Rao DS, Shih MS, Nelson D. Effects of ethnicity and age or menopause on osteoblast function, bone mineralization, and osteoid accumulation in iliac bone. J Bone Miner Res. 1997;12:1864-1873. (Pubitemid 27500198)
48. Gillooly JF, Brown JH, West GB, Savage VM, Charnov EL. Effects of size and temperature on metabolic rate. Science. 2001;293:2248-2251. (Pubitemid 32900233)
49. Parfitt AM. Osteonal and hemi-osteonal remodeling: the spatial and temporal framework for signal traffic in adult human bone. J Cell Biochem. 1994;55:273-286. (Pubitemid 24218802)
50. Schneider P, Krucker T, Meyer E, et al. Simultaneous 3D visualization and quantification of murine bone and bone vasculature using micro-computed tomography and vascular replica. Microsc Res Tech. 2009;72:690-701.
51. Hui SL, Slemenda CW, Johnston CC Jr. Age and bone mass as predictors of fracture in a prospective study. J Clin Invest. 1988;81:1804-1809.
52. Nelson JF, Felicio LS, Osterburg HH, Finch CE. Differential contributions of ovarian and extraovarian factors to age-related reductions in plasma estradiol and progesterone during the estrous cycle of C57BL/6J mice. Endocrinology. 1992;130:805-810.
53. Mobbs CV, Cheyney D, Sinha YN, Finch CE. Age-correlated and ovary-dependent changes in relationships between plasma estradiol and luteinizing hormone, prolactin, and growth hormone in female C57BL/6J mice. Endocrinology. 1985;116:813-820. (Pubitemid 15165887)
54. Finch CE, Jonec V, Wisner JR Jr, Sinha YN, de Vellis JS, Swerdloff RS. Hormone production by the pituitary and testes of male C57BL/6J mice during aging. Endocrinology. 1977;101:1310-1317. (Pubitemid 8187579)
55. Recker R, Lappe J, Davies KM, Heaney R. Bone remodeling increases substantially in the years after menopause and remains increased in older osteoporosis patients. J Bone Miner Res. 2004;19:1628-1633. (Pubitemid 41094325)
56. Seeman E. Pathogenesis of bone fragility in women and men. Lancet. 2002;359:1841-1850. (Pubitemid 34607063)
57. Parfitt AM. Bone-forming cells in clinical conditions. In: Hall BK, ed. Bone: A Treatise. Volume 1 The Osteoblast and Osteocyte. Boca Raton, FL: Telford Press and CRC Press; 1990:351-429.
58. Ambrogini E, Almeida M, Martin-Millan M, et al. FoxO-mediated defense against oxidative stress in osteoblasts is indispensable for skeletal homeostasis in mice. Cell Metab. 2010;11:136-146.
59. Weinstein RS, Wan C, Liu Q, et al. Endogenous glucocorticoids decrease skeletal angiogenesis, vascularity, hydration, and strength in aged mice. Aging Cell. 2010;9:147-161.
60. Almeida M, Ambrogini E, Han L, Manolagas SC, Jilka RL. Increased lipid oxidation causes oxidative stress, increased peroxisome proliferator- activated receptor-gamma expression, and diminished pro-osteogenic Wnt signaling in the skeleton. J Biol Chem. 2009;284:27438-27448.
61. Han ZH, Palnitkar S, Rao DS, Nelson D, Parfitt AM. Effect of ethnicity and age or menopause on the structure and geometry of iliac bone. J Bone Miner Res. 1996;11:1967-1975. (Pubitemid 26425691)
62. Weiss A, Arbell I, Steinhagen-Thiessen E, Silbermann M. Structural changes in aging bone: osteopenia in the proximal femurs of female mice. Bone. 1991;12:165-172.
63. Silbermann M, Weiss A, Reznick AZ, Eilam Y, Szydel N, Gershon D. Age-related trend for osteopenia in femurs of female C57BL/6 mice. Compr Gerontol A. 1987;1:45-51.
64. Raum K, Leguerney I, Chandelier F, et al. Bone microstructure and elastic tissue properties are reflected in QUS axial transmission measurements. Ultrasound Med Biol. 2005;31:1225-1235. (Pubitemid 41318856)
65. Jilka R, DeLoose A, Climer L, et al. Dysfunctional osteocytes increase RANKL and promote cortical pore formation in their vicinity: a mechanistic explanation for the development of cortical porosity with age. J Bone Miner Res. 2012;27:S348.
66. Mohaghegh P, Hickson ID. Premature aging in RecQ helicase-deficient human syndromes. Int J Biochem Cell Biol. 2002;34:1496-1501. (Pubitemid 35245405)
67. Burtner CR, Kennedy BK. Progeria syndromes and ageing: what is the connection? Nat Rev Mol Cell Biol. 2010;11:567-578.
68. Scaffidi P, Misteli T. Lamin A-dependent nuclear defects in human aging. Science. 2006;312:1059-1063.
69. Du X, Shen J, Kugan N, et al. Telomere shortening exposes functions for the mouse Werner and Bloom syndrome genes. Mol Cell Biol. 2004;24:8437-8446. (Pubitemid 39245066)
70. Pignolo RJ, Suda RK, McMillan EA, et al. Defects in telomere maintenance molecules impair osteoblast differentiation and promote osteoporosis. Aging Cell. 2008;7:23-31.
71. Li W, Yeo LS, Vidal C, et al. Decreased bone formation and osteopenia in lamin a/c-deficient mice. PLoS One. 2011;6:e19313.
72. Treiber N, Maity P, Singh K, et al. Accelerated aging phenotype in mice with conditional deficiency for mitochondrial superoxide dismutase in the connective tissue. Aging Cell. 2011;10:239-254.
73. Takeda T, Matsushita T, Kurozumi M, Takemura K, Higuchi K, Hosokawa M. Pathobiology of the senescence-accelerated mouse (SAM). Exp Gerontol. 1997;32:117-127. (Pubitemid 27131711)
74. Xia C, Higuchi K, Shimizu M, et al. Genetic typing of the senescenceaccelerated mouse (SAM) strains with microsatellite markers. Mamm Genome. 1999;10:235-238. (Pubitemid 29390509)
75. Silva MJ, Brodt MD, Ettner SL. Long bones from the senescence accelerated mouse SAMP6 have increased size but reduced whole-bone strength and resistance to fracture. J Bone Miner Res. 2002;17:1597-1603.
76. Jilka RL, Weinstein RS, Takahashi K, Parfitt AM, Manolagas SC. Linkage of decreased bone mass with impaired osteoblastogenesis in a murine model of accelerated senescence. J Clin Invest. 1996;97:1732-1740. (Pubitemid 26105482)
77. Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC. The effects of androgen deficiency on murine bone remodeling and bone mineral density are mediated via cells of the osteoblastic lineage. Endocrinology. 1997;138:4013-4021. (Pubitemid 27351958)
78. Kajkenova O, Lecka-Czernik B, Gubrij I, et al. Increased adipogenesis and myelopoiesis in the bone marrow of SAMP6, a murine model of defective osteoblastogenesis and low turnover osteopenia. J Bone Miner Res. 1997;12:1772-1779. (Pubitemid 27500188)
79. Moerman EJ, Teng K, Lipschitz DA, Lecka-Czernik B. Aging activates adipogenic and suppresses osteogenic programs in mesenchymal marrow stroma/stem cells: the role of PPAR-gamma2 transcription factor and TGF-beta/BMP signaling pathways. Aging Cell. 2004;3:379-389. (Pubitemid 40246708)
80. Stolzing A, Scutt A. Age-related impairment of mesenchymal progenitor cell function. Aging Cell. 2006;5:213-224. (Pubitemid 43809939)
81. Zhou S, Greenberger JS, Epperly MW, et al. Age-related intrinsic changes in human bone-marrow-derived mesenchymal stem cells and their differentiation to osteoblasts. Aging Cell. 2008;7:335-343. (Pubitemid 351663902)
82. Shimizu M, Higuchi K, Bennett B, et al. Identification of peak bone mass QTL in a spontaneously osteoporotic mouse strain. Mamm Genome. 1999;10:81-87. (Pubitemid 29390527)
83. Benes H, Weinstein RS, Zheng W, et al. Chromosomal mapping of osteopenia-associated quantitative trait loci using closely related mouse strains. J Bone Miner Res. 2000;15:626-633. (Pubitemid 30174016)
84. Shimizu M, Higuchi K, Kasai S, et al. Chromosome 13 locus, Pbd2, regulates bone density in mice. J Bone Miner Res. 2001;16:1972-1982. (Pubitemid 32995388)
85. Nakanishi R, Shimizu M, Mori M, et al. Secreted frizzled-related protein 4 is a negative regulator of peak BMD in SAMP6 mice. J Bone Miner Res. 2006;21:1713-1721. (Pubitemid 46141226)
86. Szumska D, Benes H, Kang P, et al. A novel locus on the X chromosome regulates post-maturity bone density changes in mice. Bone. 2007;40:758-766. (Pubitemid 46187224)
87. Richards JB, Zheng HF, Spector TD. Genetics of osteoporosis from genome-wide association studies: advances and challenges. Nat Rev Genet. 2012;13:576-588.
88. Farhat GN, Cauley JA, Matthews KA, et al. Volumetric BMD and vascular calcification in middle-aged women: the Study of Women's Health Across the Nation. J Bone Miner Res. 2006;21:1839-1846. (Pubitemid 44851559)
89. Hak AE, Pols HA, van Hemert AM, Hofman A, Witteman JC. Progression of aortic calcification is associated with metacarpal bone loss during menopause: a population-based longitudinal study. Arterioscler Thromb Vasc Biol. 2000;20:1926-1931. (Pubitemid 30644642)
90. Vogt MT, Wolfson SK, Kuller LH. Lower extremity arterial disease and the aging process: a review. J Clin Epidemiol. 1992;45:529-542.
91. Schulz E, Arfai K, Liu X, Sayre J, Gilsanz V. Aortic calcification and the risk of osteoporosis and fractures. J Clin Endocrinol Metab. 2004;89:4246-4253. (Pubitemid 39244420)
92. Shao JS, Cheng SL, Sadhu J, Towler DA. Inflammation and the osteogenic regulation of vascular calcification: a review and perspective. Hypertension. 2010;55:579-592.
93. Pirih F, Lu J, Ye F, et al. Adverse effects of hyperlipidemia on bone regeneration and strength. J Bone Miner Res. 2012;27:309-318.
94. Berliner JA, Watson AD. A role for oxidized phospholipids in atherosclerosis. N Engl J Med. 2005;353:9-11. (Pubitemid 41007802)
95. Steinberg D. The LDL modification hypothesis of atherogenesis: an update. J Lipid Res. 2009;50(suppl):S376-S381.
96. George J, Afek A, Shaish A, et al. 12/15-Lipoxygenase gene disruption attenuates atherogenesis in LDL receptor-deficient mice. Circulation. 2001;104:1646-1650. (Pubitemid 32947528)
97. Cyrus T, Witztum JL, Rader DJ, et al. Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient mice. J Clin Invest. 1999;103:1597-1604